* Adjusted earnings 85 cts/share, a penny over Street view
* Revenue rose 8.4 percent (Adds outlook, stock price)
CHICAGO, Oct 29 (Reuters) - Beckman Coulter BEC.N, a maker of biomedical testing instrument systems, reported lower quarterly net earnings on Thursday because of its acquisition of Olympus.
Third-quarter earnings were $1.5 million, or 2 cents per diluted share, in the third quarter, compared with $24.1 million, or 37 cents per diluted share, in the year-ago period.
Adjusted earnings per share were 85 cents. On that basis, analysts on average had expected earnings of 84 cents per share, according to Thomson Reuters I/B/E/S.
Revenue rose to $822.8 million in the quarter from $758.8 million a year ago.
The company tightened and raised its outlook for the full year to a range of $3.85 to $3.95 per fully diluted share from its previous forecast of $3.76 to $3.91 per share.
Full-year revenue is expected to be flat, or flat to up 2 percent excluding the impact of foreign currency.
The shares closed 87 cents higher at $67.06 on the New York Stock Exchange. (Reporting by Debra Sherman)